AMGNAmgen Inc.UptrendEarnings in 7 days

TodayUptrendcalm stock

Nasdaq GSDrug Manufacturers - GeneralMarket cap $237.48BReports Nov 3, 2026

Amgen Inc.

Pharmaceuticals large cap
Sector
Healthcare
Industry
Drug Manufacturers - General
Market cap
$237.48B
Employees
31,500
Exchange
Nasdaq GS
Country
United States
Website
amgen.com
444.63+1.22% todayClose of Oct 26, 2026 · end-of-day snapshot

Not sure what's inside? Read a full TSLA analysis, currently free

Figures as of Oct 26, 2026Unlock all 8$9.90one-time

Technical readingsFree

Trend state Uptrend, stage 2 of 4, no damage flags raised (as of Oct 26, 2026)

Automated read

Price is trading above its key moving averages and momentum readings are contained: the mid-term picture reads as an orderly uptrend. RSI is currently 63.

Readings, end-of-day Oct 26, 2026
RSI (14)Upper-neutral63.14, favorable reading
MACD / signalAbove signal line9.36 / 6.73, favorable reading
SMA 50Price above417.85, favorable reading
SMA 200Price above372.18, favorable reading
EMA 20Price above426.11, favorable reading
ADX (14)Trending27.80
Show all 12 readings
+DI / −DI+DI leading35.48 / 13.78, favorable reading
ATR (14)2.5% of price — typical daily swing11.11
Stochastic %KOverbought zone87.53, flagged reading
Bollinger bands (20)Inside bands393.48 – 451.80
ROC (10)Positive over 10 sessions6.48, favorable reading
Trend / momentum impulseTrend and momentum disagreeMixed
Full analysis

What unlocking AMGN reveals

Company & theme write-upWhat the company does, the themes it belongs to, and the tags that place it beside its peers.Generated on unlock
Signal historyEvery past volume signal measured forward from the day it fired.Generated on unlock
AI narrativeThe volume, technical and fundamental reads tied into one plain-language story.Generated on unlock
Catalysts & risksScheduled events set beside the risks the narrative flags, each paired to its figure.Generated on unlock
Accumulation readVolume measured against this stock's own baseline, broken down day by day.Generated on unlock

Generated on unlock: written when AMGN's analysis runs, rather than checked against its stored data now.

Every section above, argued on AMGN's own numbers, on one page.

See what AMGN costsNot sure what's inside? Read a full TSLA analysis, currently free

Unlock the full AMGN analysis

AI narrative, signals and history, social sentiment and the full fundamentals, refreshed each market day for 30 days.

  • Unlocked in about 60 seconds
  • No account needed
  • Secure checkout via Stripe

Covering a bigger list? Get 15 for $49.00: one-time, 30 days for the whole pack, swaps included.

Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get AMGN + ~23,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
Earnings

When does Amgen Inc. report earnings?

Amgen Inc. (AMGN) is scheduled to report earnings on Nov 3, 2026.

The date is confirmed rather than estimated, though companies do occasionally reschedule.

Data as of Oct 27, 2026

See who else reports soon
Data dictionary
$9.90one-time Unlock AMGN